These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9044034)

  • 41. Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
    Yadav R; Landersdorfer CB; Nation RL; Boyce JD; Bulitta JB
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2286-98. PubMed ID: 25645842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
    J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.
    Friedland IR; Paris M; Shelton S; McCracken GH
    J Antimicrob Chemother; 1994 Aug; 34(2):231-7. PubMed ID: 7814283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility of multiply antibiotic-resistant pneumococci to the new beta-lactam drugs and rosaramicin.
    Landesman SH; Cummings M; Gruarin A; Bernheimer H
    Antimicrob Agents Chemother; 1981 Apr; 19(4):675-7. PubMed ID: 7247389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meningitis with beta-lactam-resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture.
    Kleiman MD; Weinberg GA; Reynolds JK; Allen SD
    Pediatr Infect Dis J; 1993 Sep; 12(9):782-4. PubMed ID: 8414810
    [No Abstract]   [Full Text] [Related]  

  • 46. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
    Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro comparative study of piperacillin-aminoglycosides combinations against Enterococci and Enterobacteriaceae].
    Chanal M; Sirot D; Cluzel M; Sirot J; Rubio D; Joly B; Cluzel R
    Presse Med; 1986 Dec; 15(46):2313-6. PubMed ID: 2949274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Streptococcus pneumoniae and beta-lactam antibiotic agents].
    Ranin L; Vucković-Opavski N; Berger-Jekić O
    Srp Arh Celok Lek; 1996; 124(1-2):18-23. PubMed ID: 9102809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of correlation between in vitro and in vivo studies of combinations of rifampin plus vancomycin or beta-lactam antibiotics against Streptococcus pneumoniae.
    Tuban F; Cabellos C; Liñares J
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1573-4. PubMed ID: 8726045
    [No Abstract]   [Full Text] [Related]  

  • 50. [Investigation of the antibacterial activity of faropenem against Streptococcus pneumoniae].
    Hanaki H; Inaba Y; Hiramatsu K
    Jpn J Antibiot; 1999 Sep; 52(9):563-70. PubMed ID: 10746191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of penicillin MICs to predict in vitro activity of other beta-lactam antimicrobial agents against Streptococcus pneumoniae.
    Brueggemann AB; Pfaller MA; Doern GV
    J Clin Microbiol; 2001 Jan; 39(1):367-9. PubMed ID: 11136803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of activities of beta-lactam antibiotics against Streptococcus pneumoniae with recombinant penicillin-binding protein genes from a penicillin-resistant strain.
    Maeda K; Ida T; Sanbongi Y; Suzuki T; Fukushima T; Kurazono M; Yonezawa M; Ubukata K; Inoue M
    J Infect Chemother; 2005 Apr; 11(2):107-11. PubMed ID: 15856382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
    J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Resistant pneumococci: a renewed threat in respiratory infections.
    Goldstein FW; Garau J
    Scand J Infect Dis Suppl; 1994; 93():55-62. PubMed ID: 8047858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
    Azimi L; Rastegar Lari A
    Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical and bacteriological studies of Streptococcus pneumoniae. Yearly changes in isolation frequencies from clinical specimens, serotype distributions and drug susceptibilities, especially those of beta-lactam-resistant strains].
    Oguri T
    Jpn J Antibiot; 1986 Mar; 39(3):783-806. PubMed ID: 3735669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin.
    Klugman KP; Capper T
    J Antimicrob Chemother; 1997 Dec; 40(6):797-802. PubMed ID: 9462430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.
    Stucki A; Gerber P; Acosta F; Cottagnoud M; Cottagnoud P
    Antimicrob Agents Chemother; 2006 Feb; 50(2):770-3. PubMed ID: 16436742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-vitro activity of a combination of two oral beta-lactams (cefpodoxime and amoxycillin) against Streptococcus pneumoniae isolates with reduced susceptibilities to penicillin.
    Johnson DM; Jones RN
    J Antimicrob Chemother; 1998 Oct; 42(4):555-7. PubMed ID: 9818764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.